The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Purpose Bitcoin ETF
BTCC:CA
Silver47 Exploration
AGA:CC
Syntheia
SYAI:CC
Black Swan Graphene
SWAN:CC
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Big News Roundup: Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease; Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
May. 04, 2018 10:30AM PST
Biotech InvestingIn case you missed it, here is this week’s big news roundup in the Life Science sector.
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- Bion Issues Technology Update: Recent Testing Confirms Substantially Reduced Costs
- Kalytera Announces Issuance of Second Patent Covering the Use of CBD in Graft Versus Host Disease
- NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California
- Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis
This article is updated each week. Please scroll to the top for the most recent information.
Apr 27 Big News Roundup: Lexaria Enters Definitive License Agreement with California Cannabis Beverage Manufacturer; Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis; Xanthic Biopharma Inc. Advances Cannabis Opportunity In Thailand
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis
- Xanthic Biopharma Inc. President, Gary Galitsky and Board Member, Dr. Gunther Hintz, Advance Cannabis Opportunity In Thailand
- Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient
- Lexaria Enters Definitive License Agreement with California Cannabis Beverage Manufacturer
Apr 20 Big News Roundup: Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC; Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology; Isodiol International Signs Agreement to Acquire 19.9% Equity into Leading Canadian Medical Cannabis Clinic
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- RISE Life Science Corp. Announces Closing $2.2M of Equity Financing
- Kalytera Announces Issuance of Patent Covering the Use of CBD for the Treatment of Severe and Refractory Graft Versus Host Disease
- Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC, for Production and Sale of Xanthic-Infused Products in Oregon, Nevada and Ohio
- Isodiol International Inc. Signs Definitive Agreement to Acquire 19.9% Equity into Leading Canadian Medical Cannabis Clinic & Retailer
- Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology
To see our previous Life Science Investing Big News Roundups, please click here.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.